Candel Therapeutics, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -10,959.20%-20,623.20%-28,169.60%-1,299.23%-1,444.74%
EBIT Margin -11,048.00%-20,580.80%-27,777.60%-1,479.42%-1,596.70%
EBITDA Margin -14,128.80%-28,899.20%-27,777.60%-1,479.42%-1,596.70%
Operating Margin -11,048.00%-20,580.80%-27,777.60%-1,479.42%-1,596.70%
Net Margin -10,959.20%-20,623.20%-28,169.60%-1,299.23%-1,444.74%
FCF Margin -8,437.60%-19,242.40%-26,172.80%-1,337.23%-1,293.73%
Efficiency
Assets Average 63.74M83.45M
Equity Average 20.29M55.93M
Invested Capital -23.08M64.70M67.71M
Asset Utilization Ratio 0.000.00
Leverage & Solvency
Interest Coverage Ratio -20.3314.7915.97
Debt to Equity -0.020.010.42
Debt Ratio 0.010.010.26
Equity Ratio -0.620.720.61
Times Interest Earned -20.3314.7915.97
Valuation
Enterprise Value -35.05M141.71M-18.34M42.51M281.89M
Market Capitalization 224.35M51.72M42.51M281.89M
Return Ratios
Return on Sales -109.59%-206.23%-281.70%-12.99%-14.45%
Return on Capital Employed -0.44%-0.45%
Return on Assets -0.40%-0.42%
Return on Equity -1.27%-0.63%